Delivery Order SPE2DB24D2106-SPE2DB25FAWAB
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,983.53 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and performance to be fulfilled in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,478.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). The contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is structured as a firm fixed-price delivery order. The place of performance is Conshohocken, Pennsylvania. This award carries no set-aside designation, allowing the...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $1,219.75 to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two-pack units). This firm fixed-price delivery order, which must be completed by July 25, 2025, represents a routine pharmaceutical supply fulfillment under the agency's medical logistics operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of epinephrine auto-injectors. The $4,154 contract has a performance period through July 31, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to...
- This is a $1,163.12 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of epinephrine auto-injectors, with a period of performance through July 18, 2025. DMS Pharmaceutical Group has a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999, to provide a range of pharmaceutical products including branded and generic...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,394.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a completion date of June 27, 2024, is for the delivery of epinephrine injection USP 1:1000 automatic injectors to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,849.00 on August 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract carries a firm fixed-price structure with an ultimate completion date of August 6, 2025, and was issued without a set-aside designation. The award is funded by the Defense Logistics Agency's Medical Supply Chain program and will be...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,157.81, is for the delivery of epinephrine auto-injectors to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $2,644.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors with a period of performance through May 3, 2024. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the delivery of epinephrine auto-injectors. The contract has a potential value of $1,096.75 and a completion date of December 28, 2023. This Delivery Order is placed against the DMS Pharmaceutical Group's existing Indefinite Delivery Contract 4600082013 with the Defense Logistics Agency's SPE2DB program, which has a...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWABDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,395.15 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, is a critical supplier within the federal pharmaceutical supply chain serving the Department of Defense and military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a ceiling value of $499.999 billion and extends through November 2026. The IDC establishes a comprehensive pharmaceutical supply arrangement enabling the DLA to procure an extensive portfolio of medications, biologics, and medical consumables supporting military health facilities worldwide. The epinephrine auto-injector delivery aligns with the IDC's scope covering specialized pharmaceutical products and injections essential to Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/13/25 |